Rainbow Rare Earths Ltd (AIM:RBW, ASX:RRE) says its Johannesburg pilot plant is performing to plan and has produced commercial-grade rare earth product. The company says the quality de-risks the project and supports plans to move further downstream. Cloudbreak Discovery PLC (LSE:CDS) shares jumped after it moved to buy 90% of the Paterson gold-copper project in Western Australia. The company plans modern geophysics to refine drill targets near Greatland Gold’s Telfer mine. Valereum PLC (LSE:VLRM) has signed an MoU with RWA.io and Defactor to explore compliant tokenised asset issuance and distribution. The deal could boost visibility for issuers and expand access across regulated and decentralised markets. Arecor Therapeutics PLC (AIM:AREC) is in talks on a wider partnership for its Phase II ultra-concentrated insulin trial. It’s also pushing ahead with an oral GLP-1 platform, targeting better absorption and long-term growth. Wellnex Life Ltd (ASX:WNX, AIM:WNX) is reviewing takeover interest in its Pain Away brand and other assets. It’s also weighing funding options as it pushes ahead with its turnaround plan. Follow us and subscribe on YouTube, our social channels and on proactiveinvestors.co.uk. View Comments
Rainbow Rare Earths, Cloudbreak Discovery, Valereum, Arecor Therapeutics, Wellnex Life
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...